Bios Capital Management, Lp

Institutional manager — quarterly 13F holdings, Q ending 2026-03-31

Reported value
$52.9M
Q ending 2026-03-31
Prior quarter
$82.6M
Q ending 2025-12-31
Change
-36.0% QoQ · -33.2% YoY
Positions
6
reported holdings

Largest positions

All 6 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
HoldingTickerTypeValueShares
Actuate Therapeutics IncACTUShares$27.5M10.0M
Opus Genetics IncIRDShares$16.8M3.7M
Cognition Therapeutics IncCGTXShares$4.6M6.0M
Rein Therapeutics IncRNTXShares$2.6M2.0M
Lantern Pharma IncLTRNShares$1.2M864K
In8Bio IncINABShares$248K168K

Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.